SCHEMBL6403299

SCHEMBL6403299

O=C(CSc1nnc[nH]1)N1c2ccccc2Sc2ccccc21

nearest known ligand 0.63

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.63
▸ HTT P42858 3/20 0.63
▸ ALDH1A1 P00352 8/20 0.61
▸ MAPT P10636 5/20 0.61
▸ USP2 O75604 1/20 0.61
▸ LMNA P02545 5/20 0.61
▸ THRB P10828 3/20 0.61
▸ MEN1 O00255 1/20 0.61
▸ RECQL P46063 1/20 0.61
▸ NPSR1 Q6W5P4 5/20 0.56
▸ CYP1A2 P05177 2/20 0.55
▸ CYP3A4 P08684 2/20 0.55
▸ CYP2C9 P11712 2/20 0.55
▸ CYP2C19 P33261 2/20 0.55
▸ GPR55 Q9Y2T6 2/20 0.54
▸ POLB P06746 1/20 0.51
▸ GALK1 P51570 1/20 0.51
▸ SAE1 Q9UBE0 1/20 0.51
▸ UBA2 Q9UBT2 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6408123 0.79 ALDH1A1 (0.63) KMT2AHTTALDH1A1MAPTUSP2
SCHEMBL6405002 0.74 ALDH1A1 (0.64) KMT2AHTTALDH1A1MAPTUSP2
SCHEMBL12310045 0.73 ALDH1A1 (0.67) KMT2AHTTALDH1A1MAPTUSP2
SCHEMBL4795877 0.70 GAA (0.79) KMT2AHTTALDH1A1MAPTLMNA
SCHEMBL6890807 0.68 KMT2A (0.49) KMT2AALDH1A1NPSR1CYP1A2CYP2C19
SCHEMBL4556566 0.67 MAPK1 (0.68) KMT2AMAPTMEN1NPSR1POLB
SCHEMBL4759685 0.67 BCHE (0.65) KMT2AALDH1A1MAPTUSP2MEN1
SCHEMBL4759501 0.67 BCHE (0.65) KMT2AALDH1A1MAPTUSP2MEN1
SCHEMBL627575 0.67 BCHE (0.65) ALDH1A1MAPTUSP2NPSR1POLB
SCHEMBL2681239 0.67 BCHE (0.70) KMT2AALDH1A1MAPTUSP2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT KMT2A 2263/4885HTT 2113/4885ALDH1A1 720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback